|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
This pharmacy benefits manager reported an earnings miss, but we feel the stock remains a good long-term holding.
Here is a list of stocks analysts expect to increase the most over the next 12 months.
Guests include John Galt, CEO of Greenhouse Holdings, Neil Hennessy, CEO of Hennessy Funds and Sam Dedio, portfolio manager for the Artio U.S. Small Cap Fund
We believe one company has more upside and less contract risk, and that's why we swapped our positions.
We're swapping our positions in pharmacy benefit managers in order to avoid contract-expiration risk.
Upcoming contract renewals are risks for this company, so we'll sell most of our position.
The broader picture remains positive for the leading pharmacy benefits manager in the industry.
Unloved health-care stocks such as Medco and Thermo Fisher may outperform amid uncertainty.
CVS Caremark is attempting to fight its way back from a drop last month, and the bulls apparently think it will succeed.
Industrials and infrastructure will be in demand. Also, here are more high-quality names we're watching.
We'll take profits in this miner and buy more stock of a generic-drug company.
This health care stock's downside is priced in, and this tech firm is set to gain market share.
I'm selling my remaining stake in this tech play to raise cash -- I'm eager to go shopping elsewhere in the portfolio.
This selloff is affording me a good chance to get a great turnaround story on the cheap.
MedcoHealth Solutions' CEO Discusses Q4 2010 Results - Earnings Call Transcript
The latest numbers from this health name show that its fundamentals remain strong. I'm looking to pick up more shares.
Cramer says investors shouldn't get taken in by bear chatter and miss the opportunity of participating in this bull market.
I'm shutting the books on this pharma play and will look to redistribute the funds to other favored names.
This retailer reports good numbers, and this health care stock has an upcoming catalyst.
Even if the current health care bid survives adverse rulings, we like these two stocks the best.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.